Medicare Enrolled

Dr. Mario Juarez, M.D.

Family Medicine · San Antonio, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4151 CALLAGHAN RD, San Antonio, TX 78228
2106816380
In practice since 2006 (19 years)
NPI: 1073523866 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Juarez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Juarez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Juarez

Dr. Mario Juarez is a family medicine in San Antonio, TX, with 19 years in practice. Based on federal Medicare data, Dr. Juarez performed 1,711 Medicare services across 790 unique beneficiaries.

Between the years covered by Open Payments, Dr. Juarez received a total of $6,571 from 41 pharmaceutical and/or device companies across 406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Juarez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 17% volume in TX$ $6,571 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,711
Medicare services
Top 17% in TX for family medicine
790
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~90 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)1,061$56$171
Advance care planning consultation, first 30 min156$50$158
Annual wellness visit, follow-up145$123$246
Drug injection, under skin or into muscle111$9$27
Blood draw (venipuncture)87$8$18
Urinalysis, manual54$3$10
Dexamethasone injection (steroid)30$0$0
Transitional care management services for problem of at least moderate complexity16$146$388
Electrocardiogram (EKG), 12-lead14$7$27
Annual depression screening13$18$35
Injection, tobramycin sulfate, up to 80 mg13$2$5
Office visit, established patient (30-39 min)11$86$243
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,571
Total received (2018-2024)
Avg $939/year across 7 years
Top 9% in TX for family medicine
41
Companies
406
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,571 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$454
2023
$561
2022
$328
2021
$763
2020
$1,264
2019
$1,296
2018
$1,904

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,547
Lilly USA, LLC
$660
Novo Nordisk Inc
$591
Merck Sharp & Dohme Corporation
$528
Boehringer Ingelheim Pharmaceuticals, Inc.
$392
Allergan Inc.
$388
Amgen Inc.
$306
Janssen Pharmaceuticals, Inc
$278
GlaxoSmithKline, LLC.
$194
SANOFI-AVENTIS U.S. LLC
$160
Shire North American Group Inc
$149
Nevro Corp.
$148
Takeda Pharmaceuticals U.S.A., Inc.
$145
ARBOR PHARMACEUTICALS, INC.
$135
Bayer Healthcare Pharmaceuticals Inc.
$125
Abbott Laboratories
$101
Astellas Pharma US Inc
$92
PFIZER INC.
$85
ABBVIE INC.
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$53
Allergan, Inc.
$52
Shield Therapeutics Inc
$32
IDORSIA PHARMACEUTICALS US INC
$31
Circassia Pharmaceuticals Inc
$31
AbbVie Inc.
$29
Medtronic MiniMed, Inc.
$29
Agios Pharmaceuticals, Inc.
$22
Genentech USA, Inc.
$21
Ultragenyx Pharmaceutical Inc.
$18
Esperion Therapeutics, Inc.
$16
Gilead Sciences, Inc.
$16
Sumitomo Pharma America, Inc.
$16
SHIELD THERAPEUTICS INC
$15
Antares Pharma, Inc.
$15
Horizon Therapeutics plc
$14
Vanda Pharmaceuticals Inc.
$14
Merck Sharp & Dohme LLC
$14
Phathom Pharmaceuticals, Inc.
$13
Amarin Pharma Inc.
$12
Medtronic Vascular, Inc.
$11
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 42.6% of total payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AREXVY · Aimovig · BASAGLAR · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CHANTIX · ClosureFast · Cryvista · EMGALITY · EUCRISA · EVENITY · Edarbi · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GEMTESA · HETLIOZ · Horizant · INVOKANA · JANUMET · JANUVIA · JARDIANCE · Kerendia · LYRICA · MOUNJARO · MYDAYIS · MYRBETRIQ · NEXLETOL · NOCDURNA · Otezla · Otovel · Ozempic · PAXLOVID · PENNSAID · PYRUKYND · Proclaim Family of SCS IPGs · Prolia · QUVIVIQ · QVAR · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STIOLTO RESPIMAT · Senza Spinal Cord Stimulation System · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Tresiba · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · Xofluza · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for family medicine in TX.

Equivalent to $384 per 100 Medicare services performed
Looking for a family medicine in San Antonio?
Compare family medicines in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
947
Per 100K population
46.5
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
3.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Juarez is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), and high industry engagement (low-engagement, top 9%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Juarez experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Juarez performed 1,061 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Juarez receive payments from pharmaceutical companies?
Yes. Dr. Juarez received a total of $6,571 from 41 companies across 406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Juarez's costs compare to other family medicines in San Antonio?
Dr. Juarez's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Juarez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →